KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Accured Expenses (2016 - 2024)

Historic Change in Accured Expenses for Palvella Therapeutics (PVLA) over the last 6 years, with Q4 2024 value amounting to -$358000.0.

  • Palvella Therapeutics' Change in Accured Expenses changed N/A to -$358000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 18920.99% up from last year.
  • Per Palvella Therapeutics' latest filing, its Change in Accured Expenses stood at -$358000.0 for Q4 2024.
  • In the past 5 years, Palvella Therapeutics' Change in Accured Expenses registered a high of $739000.0 during Q2 2024, and its lowest value of -$358000.0 during Q4 2024.